Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. May 15, 2023; 15(5): 787-809
Published online May 15, 2023. doi: 10.4251/wjgo.v15.i5.787
Published online May 15, 2023. doi: 10.4251/wjgo.v15.i5.787
Figure 5 SOCS3 is targeted by miR-668-3p.
A: Binding sites between SOCS3 and miR-668-3p were predicted by Starbase v2.0 software; B: Dual-luciferase reporter assays were used to confirm the targeting relationship between SOCS3 and miR-668-3p in AGS and HGC-27 cells; C: Relative expression of SOCS3 in AGS and HGC-27 cells detected by western blotting following miR-668-3p overexpression; D: Relative protein expression of SOCS3 in AGS and HGC-27 cells detected by western blotting after miR-668-3p inhibition; E: Relative mRNA expression of SOCS3 was detected by quantitative real-time polymerase chain reaction in tumor tissues and normal tissues; F: Correlation between circ_0003356 and SOCS3 in gastric cancer (GC) tissues analyzed by Pearson’s correlation analysis; G: Correlation between miR-668-3p and SOCS3 in GC tissues analyzed by Pearson’s correlation analysis. bP < 0.01, cP < 0.001.
- Citation: Li WD, Wang HT, Huang YM, Cheng BH, Xiang LJ, Zhou XH, Deng QY, Guo ZG, Yang ZF, Guan ZF, Wang Y. Circ_0003356 suppresses gastric cancer growth through targeting the miR-668-3p/SOCS3 axis. World J Gastrointest Oncol 2023; 15(5): 787-809
- URL: https://www.wjgnet.com/1948-5204/full/v15/i5/787.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i5.787